Moneycontrol PRO
UPCOMING EVENT:Know how Global Investing can be spread beyond the US markets by joining an engaging webinar on November 30, 11:30 a.m.
you are here: HomeNewsIndia

COVID-19: Kerala logs 9,445 new cases, 622 deaths

With 6,723 more people recovering from the virus since Tuesday, the total recoveries touched 48,31,468 and the active cases dropped to 76,554, the release said.

October 27, 2021 / 07:19 PM IST
Source: Reuters

Source: Reuters

In an uptick in daily fresh infections, Kerala on Wednesday recorded 9,445 new coronavirus cases and 622 related deaths which raised the caseload to 49,29,397 and toll to 29,977. The state had registered 7,163 fresh infections yesterday.

Of the 622 deaths, 93 were reported in the last few days, 330 were those which were not confirmed until June 18 last year due to lack of adequate documentation and 199 were designated as COVID deaths after receiving appeals based on the new guidelines of the Centre and Supreme Court directions, a state government release said.

With 6,723 more people recovering from the virus since Tuesday, the total recoveries touched 48,31,468 and the active cases dropped to 76,554, the release said.

As many as 82,689 samples were tested in the last 24 hours.

Among the 14 districts, Ernakulam recorded the highest with 1,517 cases, followed by Thiruvananthapuram (1,284), Kozhikode (961) and Thrissur (952).

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Of the new cases, 51 were health workers, 28 from outside the state and 9,069 infected through contact with the source of it not being clear in 297.

There are currently 2,68,639 people under surveillance in various districts, of whom 2,60,359 are in home or institutional quarantine and 8,280 in hospitals.
PTI
first published: Oct 27, 2021 07:18 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark